Cord Blood Stem Cell Awareness Month was launched in India by Cryo-Save, Europe’s leading stem cell bank which announced September as the Cord Blood Stem Cell Awareness Month in India.
Cord blood stem cells have generated unprecedented excitement in medical research, for enabling remarkable breakthroughs in the treatment of several diseases and disorders.
Cryo-Save, Europe’s leading stem cell bank announced September as their
Cord Blood Stem Cell Awareness Month in India bringing together organizations and individuals around the country to become aware and spread the message about the latest advancements in medical science that can save thousands of lives. Cord Blood Stem Cell Awareness Month is a public education initiative linking researchers, doctors, patients and the general public around the country. It provides a platform to appreciate the scientific and clinical developments on stem cells, unfolding the speculations and myths around the concept and thereby encouraging more people to store cord blood stem cells.
Cord blood stem cells in the purest form have the potential to treat many devastating, degenerative and induced diseases of the heart, lung, brain, kidney and nervous system including Alzheimer's and Parkinson's disease, autoimmune diseases such as multiple sclerosis, type 1 diabetes and rheumatoid arthritis, immunodeficiencies and blood disorders. Globally around 25.3% of stem cell therapies are done to treat cancer and various neural diseases. Ongoing research and study is certain to explore many more ways of sustaining and safeguarding human lives from such disease threats.
Cryo-Save has taken the initiative to foster greater understanding about cord blood stem cell storage and also its potential applications for various life threatening diseases. Speaking on the occasion of the launch on Sept 14, Tuesday, Dr Parijatha Rao, Director, Laboratory Operations, Cryo-Save India, said, “We would like to encourage more expectant mothers to store the cord blood as it can extend the mother’s care for a lifetime and thereby ensure the future health of the child”.
Dr. Prabhu, Head-Haematology Global Hospital and Health City, Cryo-Save India added that “The general awareness about the concept of Cord blood stem cells and its clinical applications is low in India; thereby this kind of awareness initiative can help expectant mothers to take decision wisely”
Emphasizing the importance of storing cord blood for future use, Dr Aruna Chandrasekharan, Senior Consultant–Surgical Oncology, Global Hospitals & Health City, Chennai said, “Today cord blood stem cells are successfully used to treat nearly 80 diseases like childhood lymphoid cancers, immune deficiencies, blood disorders and several metabolic disorders like Gaucher’s disease. Ongoing research will explore therapies for various other diseases in the near future. The community must therefore make a concerted effort to support such research and increasing public awareness about cord blood banking is essential. To-day’s research is tomorrow’s treatment.”
Cryo-Save India, a 100% subsidiary of Cryo Save Group N.V which is Europe’s largest adult stem cell storage bank, is headquartered in Bangalore with a state-of-the art fully automated adult stem-cell storage facility. Cryo-Save Group N.V. (AIM: CRYO) is Europe’s largest adult stem cell storage bank, with more than 135,000 samples stored. Cryo-Save guarantees, for its service "CryoCord", the highest quality standards in terms of transport, preparation and security of your child’s stored umbilical cord blood.
Advertisement
Source-Medindia
